Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 117581
Gene Symbol: TWIST2
TWIST2
0.730 GermlineCausalMutation disease ORPHANET Our results suggest that autosomal-dominant TWIST2 mutations cause AMS or BSS by inducing protean effects on the transcription factor's DNA binding. 26119818 2015
Entrez Id: 117581
Gene Symbol: TWIST2
TWIST2
0.730 CausalMutation disease CLINVAR
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.010 AlteredExpression disease BEFREE IL10 was downregulated and both IF17F and CCL8 were upregulated in AMS individuals. 28611780 2017
Entrez Id: 406924
Gene Symbol: MIR134
MIR134
0.010 AlteredExpression disease BEFREE Salivary miR-134-3p and miR-15b-5p were significantly up-regulated in AMS- individuals as compared to the AMS+ (<i>p</i> < 0.05). 31379603 2019
Entrez Id: 406949
Gene Symbol: MIR15B
MIR15B
0.010 AlteredExpression disease BEFREE Salivary miR-134-3p and miR-15b-5p were significantly up-regulated in AMS- individuals as compared to the AMS+ (<i>p</i> < 0.05). 31379603 2019
Entrez Id: 6696
Gene Symbol: SPP1
SPP1
0.010 AlteredExpression disease BEFREE We explore the role of the predicted decrease in plasma OPN levels in humans upon high-altitude exposure and its relationship with acute mountain sickness (AMS), as well as superoxide dismutase (SOD) and malondialdehyde (MDA). 30165389 2018
Entrez Id: 6355
Gene Symbol: CCL8
CCL8
0.010 AlteredExpression disease BEFREE IL10 was downregulated and both IF17F and CCL8 were upregulated in AMS individuals. 28611780 2017
Entrez Id: 117581
Gene Symbol: TWIST2
TWIST2
0.730 Biomarker disease CTD_human
Entrez Id: 117581
Gene Symbol: TWIST2
TWIST2
0.730 Biomarker disease GENOMICS_ENGLAND Our results suggest that autosomal-dominant TWIST2 mutations cause AMS or BSS by inducing protean effects on the transcription factor's DNA binding. 26119818 2015
Entrez Id: 117581
Gene Symbol: TWIST2
TWIST2
0.730 Biomarker disease GENOMICS_ENGLAND CONGENITAL ECTODERMAL DYSPLASIA OF THE FACE. 14069095 1963
Entrez Id: 117581
Gene Symbol: TWIST2
TWIST2
0.730 Biomarker disease GENOMICS_ENGLAND
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
0.050 Biomarker disease BEFREE In this paper, the therapeutic mechanism of R rosea for AMS was investigated by analysis of the relationship between R rosea compositions and hypoxia-inducible factor 1 (HIF-1) degradation pathway.System biology and network biology, computational approaches were used to explore the molecular mechanisms of traditional Chinese medicine (TCM).Our results showed that chemical compositions of R rosea could inhibit the targets of HIF-1 degradation pathway in multi-composition/multi-target ways.We conclude that the 18 components with more than 2 targets and 5 targets (arrest-defective-1 [ARD1], forkhead transcription factor [FOXO4], osteosarcoma-9 [OS-9], prolyl hydroxylase 2 [PHD2], human double minute 2 [Hdm2]) deserve to be noticed, and PHD2, receptor for activated C-kinase1 (RACK1) and spermidine/spermine-N1-acetyltransferase-1 (SSAT1) may be the targets of active ingredients of rhodionin, rhodiosin, and rhodiolatuntoside, respectively. 30278484 2018
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
0.050 Biomarker disease BEFREE Though increased HIF-1α expression is associated with adaptation and protection from AMS development in the early stage of hypoxia, a downstream effector of HIF-1α, VEGF, can induce overzealous endothelial barrier dysfunction, increase vascular permeability, and ultimately result in HAPE and high-altitude cerebral edema. 31461385 2019
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
0.050 Biomarker disease BEFREE Two low oxygen sensors, Egl nine homolog 1 (EGLN1) and hypoxia-inducible factor 1-α inhibitor (HIF-1AN), play pivotal roles in the regulation of HIF-1α, and high altitude adaption may be involved in the pathology of acute mountain sickness (AMS). 25431923 2014
Entrez Id: 54583
Gene Symbol: EGLN1
EGLN1
0.030 Biomarker disease BEFREE In this paper, the therapeutic mechanism of R rosea for AMS was investigated by analysis of the relationship between R rosea compositions and hypoxia-inducible factor 1 (HIF-1) degradation pathway.System biology and network biology, computational approaches were used to explore the molecular mechanisms of traditional Chinese medicine (TCM).Our results showed that chemical compositions of R rosea could inhibit the targets of HIF-1 degradation pathway in multi-composition/multi-target ways.We conclude that the 18 components with more than 2 targets and 5 targets (arrest-defective-1 [ARD1], forkhead transcription factor [FOXO4], osteosarcoma-9 [OS-9], prolyl hydroxylase 2 [PHD2], human double minute 2 [Hdm2]) deserve to be noticed, and PHD2, receptor for activated C-kinase1 (RACK1) and spermidine/spermine-N1-acetyltransferase-1 (SSAT1) may be the targets of active ingredients of rhodionin, rhodiosin, and rhodiolatuntoside, respectively. 30278484 2018
Entrez Id: 29072
Gene Symbol: SETD2
SETD2
0.030 Biomarker disease BEFREE In this paper, the therapeutic mechanism of R rosea for AMS was investigated by analysis of the relationship between R rosea compositions and hypoxia-inducible factor 1 (HIF-1) degradation pathway.System biology and network biology, computational approaches were used to explore the molecular mechanisms of traditional Chinese medicine (TCM).Our results showed that chemical compositions of R rosea could inhibit the targets of HIF-1 degradation pathway in multi-composition/multi-target ways.We conclude that the 18 components with more than 2 targets and 5 targets (arrest-defective-1 [ARD1], forkhead transcription factor [FOXO4], osteosarcoma-9 [OS-9], prolyl hydroxylase 2 [PHD2], human double minute 2 [Hdm2]) deserve to be noticed, and PHD2, receptor for activated C-kinase1 (RACK1) and spermidine/spermine-N1-acetyltransferase-1 (SSAT1) may be the targets of active ingredients of rhodionin, rhodiosin, and rhodiolatuntoside, respectively. 30278484 2018
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.030 Biomarker disease BEFREE Plasma VEGF at 14, 200 feet for subjects with AMS (62 +/- 12 pg/mL; n = 15) did not differ significantly from subjects at 14,200 feet without AMS, or from control subjects at sea level. 10893358 2000
Entrez Id: 29072
Gene Symbol: SETD2
SETD2
0.030 Biomarker disease BEFREE Independent predictors of significant state anxiety included female sex, lower age, higher heart rate and increasing LLS and AMS-C scores (p<0.0001). 29927953 2018
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.030 Biomarker disease BEFREE In addition, erythropoietin and vascular endothelial growth factor were 1.69 and 1.75 times higher, respectively, in those with AMS. 31189189 2019
Entrez Id: 54583
Gene Symbol: EGLN1
EGLN1
0.030 Biomarker disease BEFREE To assess the association between EGLN1 and HIF-1AN SNPs and AMS in a Han Chinese population, a case-control study was performed including 190 patients and 190 controls. 25431923 2014
Entrez Id: 2056
Gene Symbol: EPO
EPO
0.020 Biomarker disease BEFREE In addition, erythropoietin and vascular endothelial growth factor were 1.69 and 1.75 times higher, respectively, in those with AMS. 31189189 2019
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
0.010 Biomarker disease BEFREE In this paper, the therapeutic mechanism of R rosea for AMS was investigated by analysis of the relationship between R rosea compositions and hypoxia-inducible factor 1 (HIF-1) degradation pathway.System biology and network biology, computational approaches were used to explore the molecular mechanisms of traditional Chinese medicine (TCM).Our results showed that chemical compositions of R rosea could inhibit the targets of HIF-1 degradation pathway in multi-composition/multi-target ways.We conclude that the 18 components with more than 2 targets and 5 targets (arrest-defective-1 [ARD1], forkhead transcription factor [FOXO4], osteosarcoma-9 [OS-9], prolyl hydroxylase 2 [PHD2], human double minute 2 [Hdm2]) deserve to be noticed, and PHD2, receptor for activated C-kinase1 (RACK1) and spermidine/spermine-N1-acetyltransferase-1 (SSAT1) may be the targets of active ingredients of rhodionin, rhodiosin, and rhodiolatuntoside, respectively. 30278484 2018
Entrez Id: 406927
Gene Symbol: MIR136
MIR136
0.010 Biomarker disease BEFREE With multiple logistic regression analysis, a unique signature encompassing miR-369-3p, miR-449b-3p, and miR-136-3p discriminate AMS from Non-AMS (area under the curve 0.986, 95%CI 0.970-1.000, <i>P</i> < 0.001, LR+: 14.21, LR-: 0.08). 28228730 2017
Entrez Id: 4303
Gene Symbol: FOXO4
FOXO4
0.010 Biomarker disease BEFREE In this paper, the therapeutic mechanism of R rosea for AMS was investigated by analysis of the relationship between R rosea compositions and hypoxia-inducible factor 1 (HIF-1) degradation pathway.System biology and network biology, computational approaches were used to explore the molecular mechanisms of traditional Chinese medicine (TCM).Our results showed that chemical compositions of R rosea could inhibit the targets of HIF-1 degradation pathway in multi-composition/multi-target ways.We conclude that the 18 components with more than 2 targets and 5 targets (arrest-defective-1 [ARD1], forkhead transcription factor [FOXO4], osteosarcoma-9 [OS-9], prolyl hydroxylase 2 [PHD2], human double minute 2 [Hdm2]) deserve to be noticed, and PHD2, receptor for activated C-kinase1 (RACK1) and spermidine/spermine-N1-acetyltransferase-1 (SSAT1) may be the targets of active ingredients of rhodionin, rhodiosin, and rhodiolatuntoside, respectively. 30278484 2018
Entrez Id: 8260
Gene Symbol: NAA10
NAA10
0.010 Biomarker disease BEFREE In this paper, the therapeutic mechanism of R rosea for AMS was investigated by analysis of the relationship between R rosea compositions and hypoxia-inducible factor 1 (HIF-1) degradation pathway.System biology and network biology, computational approaches were used to explore the molecular mechanisms of traditional Chinese medicine (TCM).Our results showed that chemical compositions of R rosea could inhibit the targets of HIF-1 degradation pathway in multi-composition/multi-target ways.We conclude that the 18 components with more than 2 targets and 5 targets (arrest-defective-1 [ARD1], forkhead transcription factor [FOXO4], osteosarcoma-9 [OS-9], prolyl hydroxylase 2 [PHD2], human double minute 2 [Hdm2]) deserve to be noticed, and PHD2, receptor for activated C-kinase1 (RACK1) and spermidine/spermine-N1-acetyltransferase-1 (SSAT1) may be the targets of active ingredients of rhodionin, rhodiosin, and rhodiolatuntoside, respectively. 30278484 2018